2012;482(7384):226–231. 3. Wu G, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet . 2012;44(3):251–253. 4. Chheda ZS, et al. Novel and shared neoanti- gen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med . 2018;215(1):141–157 . 5. Keskin DB, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glio - blastoma trial. Nature.